ASCO 2022: Biomarker guidance allows patients 55 or older with low-grade luminal A-type breast cancer to avoid radiation therapy
Based on guidance from biomarker screening, patients who are 55 years of age and older…
Browsing: Featured Events
ASCO 2022: Novel antibody-drug conjugate doubles progression-free survival in metastatic breast cancer with low HER2 expression levels
The use of trastuzumab deruxtecan (Enhertu), a new HER2-targeting antibody-drug conjugate, doubled progression-free survival compared…
ASCO 2022: Next-generation immunotherapy drug shows continued promise in several advanced-stage cancers
Initial study results show that an experimental drug, called nemvaleukin alfa, when used alone or…
ASCO 2022: Patient-facing screening tool could increase detection of individuals with inherited cancer risk
Nearly one million people in the United States are affected by Lynch syndrome – a…
ASCO GU 2022: Enfortumab vedotin is effective in patients with aggressive bladder cancer
Findings from a new study led by Yale Cancer Center researchers show enfortumab vedotin is effective in…
Genetics and availability of treatments influence the management of head and neck cancer in Asia
The Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines was presented at the ESMO Asia…
What is the impact of first-line nivolumab on subsequent therapy choices for metastatic gastric cancer?
Knock-on effects of early immune checkpoint inhibitor use stimulate consideration of alternative approaches for further…
New data for management of hepatocellular carcinoma
The COSMIC-312 trial met its primary endpoint of progression-free survival, but interim overall survival results…
Should renal cell carcinomas be managed differently in Asia?
The Pan-Asian adaptation of the ESMO guidelines introduces some changes to the standard of care…
Professor Mark Smithers receives John Zalcberg OAM Award for his dedication to gastro-intestinal cancer research
Surgical oncologist Professor Mark Smithers AM was honoured for his 30-year commitment to discovering better…